DBV Technologies
DBVT
71 hedge funds and large institutions have $434M invested in DBV Technologies in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 10 closing their positions.
190% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 10
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
44% more capital invested
Capital invested by funds: $302M → $434M (+$131M)
37% more funds holding
Funds holding: 52 → 71 (+19)
0% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 13
2.24% less ownership
Funds ownership: 40.28% → 38.04% (-2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$88.1M |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$21.2M |
| 3 |
PA
Perceptive Advisors
New York
|
+$20.1M |
| 4 |
DFO
Duquesne Family Office
New York
|
+$8.01M |
| 5 |
PSC
Patient Square Capital
Menlo Park,
California
|
+$6.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$22.8M |
| 2 |
YCM
Yiheng Capital Management
San Francisco,
California
|
-$9.81M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$8.71M |
| 4 |
Millennium Management
New York
|
-$6.72M |
| 5 |
VPC
Vestal Point Capital
New York
|
-$5.75M |
DBVT Hedge Fund Activity: Q1 2026 in Review
71 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in DBV Technologies (DBVT) for Q1 2026, worth a combined $434M — up 44% from $302M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new DBVT positions and 10 closed out — a net gain of 19 holders — while 13 added to existing stakes and 13 trimmed.
The largest buyer was MPM BioImpact, adding an estimated $88.1M. The largest seller was Artisan Partners, cutting an estimated $22.8M.
- 71 institutional investors held DBV Technologies (DBVT) as of Q1 2026, up from 52 in Q4 2025.
- Funds reported $434M of DBV Technologies stock for Q1 2026, up 44% quarter-over-quarter.
- 29 funds opened new DBV Technologies positions in Q1 2026 and 10 closed out, a net change of +19 holders.
- The largest DBV Technologies buyer in Q1 2026 was MPM BioImpact, an estimated $88.1M added.
- The largest DBV Technologies seller in Q1 2026 was Artisan Partners, an estimated $22.8M sold.
Based on aggregated 13F filings for Q1 2026.